> Pharmion and GPC Biotech say that an independent monitoring board will conduct an expedited review of survival data from the Phase III trial of Satraplatin. The companies cautioned against reading too much into the expedited review. Report
> The FDA has approved Teva's Azilect for Parkinson's disease. Teva is also planning a large trial on Azilect's influence on the progression of Parkinson's. Report
> Novartis says an FDA panel has issued a favorable opinion on its Alzheimer's drug Exelon. Report
> Seven in 10 doctors say that the recent high-profile safety problems of certain prescription drugs had made them more wary about a drug's side effects and more likely to prescribe a drug that had been out on the market longer. Release
> Baxter and Jerini are reporting progress in their collaboration to develop new therapies for hemophilia. Report
> Shire Laboratories has filed a patent suit against Corepharma. Report
> Valeant Pharmaceuticals has sold a manufacturing facility in Warsaw, Poland. Report
> China Biopharmaceuticals has reached a deal to purchase all of the shares in RACP Pharmaceutical Holdings and its wholly owned subsidiaries, including Shenyang Enshi Pharmaceutical. Release
And Finally… A family cluster of avian flu deaths in Indonesia has raised worries that the disease may have mutated into a more easily transmissible virus. Article